Risk factors for adverse cutaneous reactions associated with intravenous vancomycin

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 3, 1997, Pages 371-381

  Korman, Tony M ^a   Turnidge, John D ^a   Lindsay Grayson, M ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; SKIN MANIFESTATION;

EID: 0030957436     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jac.a020861     Document Type: Article

References (52)

1. Ena, J., Dick, R. W., Jones, R. N. & Wenzel, R. P. (1993). The epidemiology of intravenous vancomycin usage in a university teaching hospital. A 10-year study. Journal of the American Medical Association 269, 598-602.
2. Sorrell, T. C. & Collignon, P. J. (1985). A prospective study of adverse reactions associated with vancomycin therapy. Journal of Antimicrobial Chemotherapy 16, 235-41.
3. Healy, D. P., Polk, R. E., Garson, M. L, Rock, D. T. & Comstock, T. J. (1987). Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers. Antimicrobial Agents and Chemotherapy 31, 393-7.
4. Polk, R. E., Healy, D. P., Schwartz, L. B., Rock, D. T., Garson, M. L. & Roller, K. (1988). Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. Journal of Infectious Diseases 157, 502-7.
5. Sahai, J., Healy, D. P., Shelton, M. J., Miller, J. S., Ruberg, S. J. & Polk, R. (1990). Comparison of vancomycin- and teicoplanin-induced histamine release and "red man syndrome". Antimicrobial Agents and Chemotherapy 34, 765-9.
6. Wallace, M. R., Mascola, J. R. & Oldfield, E. C. (1991). Red man syndrome: incidence, etiology, and prophylaxis. Journal of Infectious Diseases 164, 1180-5.
7. Ryback, M. J., Bailey, E. M. & Warbasse, L. H. (1992). Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin. Antimicrobial Agents and Chemotherapy 36, 1204-7.
8. O'Sullivan, T. L., Ruffing, M. J., Lamp, K. C., Warbasse, L. H. & Ryback, M. J. (1993). Prospective evaluation of red man syndrome in patients receiving vancomycin. Journal of Infectious Diseases 168, 773-6.
9. Adverse Drug Reactions Advisory Committee, Australian Drug Evaluation Committee. (1992). Australian Registry of Suspected Adverse Reactions to Drugs. Australian Government Publishing Service, Canberra.
10. Polk, R. E. (1991). Anaphylactoid reactions to glycopeptide antibiotics. Journal of Antimicrobial Chemotherapy 27, Suppl. B, 17-29.
11. Sahai, J. V., Polk, R. E., Schwartz, L. B., Healy, D. P. & Westin, E. H. (1988). Severe reaction to vancomycin not mediated by histamine release and documented by rechallenge. Journal of Infectious Diseases 158, 1413-4.
12. Rawlinson, W. D. & George, C. R. (1987), Vancomycin-induced vasculitis. Medical Journal of Australia 147, 470.
13. Gutfeld, M. B., Reddy, P. V. & Morse, G. D. (1988). Vancomycin-associated exfoliative dermatitis during cutaneous ambulatory peritoneal dialysis. Drug Intelligence and Clinical Pharmacy 22, 881-2.
14. Neal, D., Morton, R., Bailie, G. R. & Waldek, S. (1988). Exfoliative reaction to vancomycin. British Medical Journal 296, 137.
15. Forrence, E. A. & Goldman, M. P. (1990). Vancomycin-associated exfoliative dermatitis. Drug Intelligence and Clinical Pharmacy 24, 369-71.
16. Laurencin, C. T., Horan, R. F., Senatus, P. B., Wheeler, C. B. & Lipson, S. J. (1992). Stevens-Johnson-type reaction with vancomycin treatment. Annals of Pharmacotherapy 26, 1520-1.
17. Baden, L. A., Apovian, C., Imber, M. J. & Dover, J. S. (1988). Vancomycin-induced linear IgA bullous dermatosis. Archives of Dermatology 124, 1186-8.
18. Carpenter, S., Berg, D., Sidhu-Malik, N., Hall, R. P. & Rico, M. J. (1992). Vancomycin-associated linear IgA dermatosis. Journal of the American Academy of Dermatology 26, 45-8.
19. Kuechle, M. K., Stegemeir, E., Maynard, B., Gibson, L. E., Leiferman, K. M. & Peters, M. S. (1994). Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. Journal of the American Academy of Dermatology 30, 187-92.
20. Piketty, C., Meeus, F., Nochy, D., Poux, J. M., Jacquot, C. & Bariety, J. (1994). Linear IgA dermatosis related to vancomycin. British Journal of Dermatology 130, 130-1.
21. Richards, S. S., Hall, S., Yokel, B. & Whitmore, S. E. (1995). A bullous eruption in an elderly woman. Vancomycin-associated linear IgA dermatosis (LAD). Archives of Dermatology 131, 1447-8, 1450-1.
22. Geissmann, C., Beylot-Barry, M., Doutre, M. S. & Beylot, C. (1995). Drug-induced linear IgA bullous dermatosis. Journal of the American Academy of Dermatology 32, 296.
23. Geraci, J. E., Nichols, D. R. & Wellman, W. E. (1962). Vancomycin in serious staphylococcal infections. Archives of Internal Medicine 109, 507-15.
24. Farber, B. F. & Moellering, R. C. (1983). Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrobial Agents and Chemotherapy 23, 138-41.
25. Sahai, J., Healy, D. P., Garris, R., Berry, A. & Polk, R. E. (1989). Influence of antihistamine pretreatment on vancomycin-induced red-man syndrome. Journal of Infectious Diseases 160, 876-81.
26. Levy, M., Koren, G., Dupuis, L. & Read, S. E. (1990). Vancomycin-induced red man syndrome. Pediatrics 86, 572-80.
27. O'Sullivan, T. L. & Rybak, M. J. (1994). Prospective evaluation of red man syndrome. Journal of Infectious Diseases 169, 700-1.
28. Rolston, K. V. I. & Hoy, J. (1986). Man/woman achieves whole red personhood through vancomycin. Journal of the American Medical Association 255, 2445.
29. Healy, D. P., Sahai, J. V., Fuller, S. H. & Polk, R. E. (1990). Vancomycin-induced histamine release and "red man syndrome": comparison of 1- and 2-hour infusions. Antimicrobial Agents and Chemotherapy 34, 550-4.
30. Daly, B. M. & Sharkey, I. (1986). Nifedipine and vancomycin-associated red man syndrome. Drug Intelligence and Clinical Pharmacy 20, 986.
31. Packer, J., Olshan, A. R. & Schwarte, A. B. (1987). Prolonged allergic reaction to vancomycin in end-stage renal disease. Dialysis and Transplantation 16, 86, 88.
32. Clayman, M. D. & Capaldo, R. A. (1989). Vancomycin allergy presenting as fever of unknown origin. Annals of Internal Medicine 149, 1425-6.
33. Cole, D. R., Oliver, M., Coward, R. A. & Brown, C. B. (1985). Allergy, red man syndrome, and vancomycin. Lancet ii, 280.
34. Markowitz, N., Quinn, E. L. & Saravolatz, L. D. (1992). Trimethoprim - sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Annals of Internal Medicine 117, 390-8.
35. Smith, S. R., Cheesbrough, J., Spearing, R. & Davies, J. M. (1989). Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters. Antimicrobial Agents and Chemotherapy 33, 1193-7.
36. McElrath, M. J., Goldberg, D. & Neu, H. C. (1986). Allergic cross-reactivity of teicoplanin and vancomycin. Lancet i, 47.
37. Dubettier, S., Boibieux, A., Lagable, M., Crevon, L., Peyramond, D. & Milon, H. (1991). Red man syndrome with teicoplanin. Reviews of Infectious Diseases 13, 770.
38. Grek, V., Andrien, F., Collignon, J. & Fillet, G. (1991). Allergic cross-reaction of teicoplanin and vancomycin. Journal of Antimicrobial Chemotherapy 28, 476-7.
39. Davenport, A. (1993). Allergic cross-reactivity to teicoplanin and vancomycin. Nephron 63, 482.
40. Schlemmer, B., Falkman, H., Boudjadja, A., Jacob, L. & LeGall, J. R. (1988). Teicoplanin for patients allergic to vancomycin. New England Journal of Medicine 318, 1127-8.
41. Smith, S. R., Cheesbrough, J. S., Makris, M. & Davies, J. M. (1989). Teicoplanin administration in patients experiencing reactions to vancomycin. Journal of Antimicrobial Chemotherapy 23, 810-2.
42. Wood, G. & Whitby, M. (1989). Teicoplanin in patients who are allergic to vancomycin. Medical Journal of Australia 150, 668.
43. Knudsen, J. D. & Pedersen, M. (1992), IgE-mediated reaction to vancomycin and teicoplanin after treatment with vancomycin. Scandinavian Journal of Infectious Diseases 24, 395-6.
44. Lerner, A. & Dwyer, J. M. (1984). Desensitization to vancomycin. Annals of Internal Medicine 100, 157.
45. Lin, R. Y. (1990). Desensitization in the management of vancomycin hypersensitivity. Archives of Internal Medicine 150, 2197-8.
46. Wong, J. T., Ripple, R. E., MacLean, J. A., Marks, D. R. & Bloch, K. J. (1994). Vancomycin hypersensitivity: synergism with narcotics and "desensitization" by a rapid continuous intravenous protocol. Journal of Allergy and Clinical Immunology 94, 189-94.
47. Griffith, R. S. (1984). Vancomycin use - an historical review. Journal of Antimicrobial Chemotherapy 14, Suppl. D, 1-5.
48. Wang, L.-S., Liu, C.-Y., Wang, F.-D., Fung, C. P., Chiu, Z. H. & Cheng, D. L. (1988). Chromatographically purified vancomycin: therapy of serious infections caused by Staphylococcus aureus and other Gram-positive bacteria. Clinical Therapeutics 10, 574-84.
49. Muoghalu, B. U. & Lattimer, G. L. (1988). Delayed red neck syndrome with generic vancomycin. Drug Intelligence and Clinical Pharmacy 22, 173.
50. Conley, N. S., Weiner, R. S. & Hiemenz, J. W. (1991). Rigors with vancomycin. Annals of Internal Medicine 115, 330.
51. Hudson, B. J., Elliott, P. A., Kilminster, I. M. & Walter, M. D. (1995). A study of adverse effects following vancomycin administration. Australian Journal of Hospital Pharmacy 25, 257-9.
52. Inman, E. L. & Winely, C. L. (1994). Analytical quantitation and characterization. In Glycopeptide Antibiotics (Nagarajan, R., Ed.), pp. 243-72. Marcel Dekker, New York, NY.